首页> 外文会议>World biomaterials congress >Encapsulation of proteins in micro- and nano-hydrogel carrier systems for controlled drug delivery
【24h】

Encapsulation of proteins in micro- and nano-hydrogel carrier systems for controlled drug delivery

机译:蛋白质在微和纳米水凝胶载体系统中的包裹以控制药物的输送

获取原文

摘要

Introduction: Therapeutic proteins like antibodies or signaling proteins have a high potential for pharmaceutical applications. Drug delivery systems are needed to protect these proteins from in-vivo degradation. Furthermore, the proteins are able to induce unwanted side effects. A local administration close to the diseased area and a slow drug release can minimize these effects. Hydrogels provide a protein friendly environment and can have good biocompatibility. Therefore they are well suited as drug delivery systems. Diffusion and/or degradation are the main release mechanism. The relation between network structure and release was studied for bulk hydrogels and micro gels. Furthermore the in vitro and in-vivo release was studied and compared. Materials and Methods: Hydroxyethyl starch was modified with polyethylene glycolmethacrylate HES-PEGMA, which can be photochemically cross-linked in aqueous solution in order to obtain hydrogels or injectable hydrogel microspheres. The release was investigated and correlated with the mesh size. Green fluorescent protein (GFP) loaded hydrogels have been analyzed by fluorescence methods with two-photon excitation. Via fluorescence anisotropy the inner rotational motions can be studied. Fluorescence recovery after photo-bleaching (FRAP) gives information about the translational diffusion. In vitro release rates were compared with in vivo release rates employing fluorescently labelled proteins and an IVIS®-system. Furthermore, a nanogel system prepared from chitosan and tripolyphosphate (TPP) was investigated regarding entrapment efficiency and release of signaling proteins. Fig.1: Chemical structure of the HES derivatives Fig. 2: Bulk hydrogels and injectabie micro particles were prepared from the HES derivatives Results and Discussion: The mesh size of the hydrogel network can be adjusted via the degree of substitution and the polymer concentration. The bulk hydrogels and the micro particles have similar structures and release profiles when prepared from the same polymer and concentration. The results of the fluorescence anisotropy suggest an unrestricted GFP rotation within the hydrogel, while the FRAP measurements indicate that translational mobility of GFP is restricted in the hydrogel. The comparison of in vitro and in vivo release rates indicates a good comparability depending on the acceptor medium used in the in vitro experiments. The chitosan/TPP nanoparticles are well suited to deliver biologically active BMP2. Conclusions: Hydrogels as micro- or nanoparticles are well suited for delivery of therapeutic proteins. By adjusting the preparation methods the drug release can be tailored.
机译:简介:治疗性蛋白质(例如抗体或信号蛋白)在制药领域具有很高的潜力。需要药物递送系统来保护这些蛋白质免于体内降解。此外,蛋白质能够诱导不想要的副作用。靠近患病区域的局部给药和缓慢的药物释放可使这些影响最小化。水凝胶提供蛋白质友好的环境,并具有良好的生物相容性。因此,它们非常适合用作药物输送系统。扩散和/或降解是主要的释放机制。研究了本体水凝胶和微凝胶的网络结构与释放之间的关系。此外,研究和比较了体外和体内释放。材料和方法:羟乙基淀粉用聚甲基丙烯酸乙二醇酯HES-PEGMA改性,可以在水溶液中进行光化学交联以获得水凝胶或可注射的水凝胶微球。研究了释放量,并将其与筛孔尺寸相关联。载有绿色荧光蛋白(GFP)的水凝胶已通过荧光法和双光子激发进行了分析。通过荧光各向异性,可以研究内部旋转运动。光漂白后的荧光恢复(FRAP)提供了有关平移扩散的信息。使用荧光标记的蛋白质和系统,将体外释放速率与体内释放速率进行了比较。此外,研究了由壳聚糖和三聚磷酸盐(TPP)制备的纳米凝胶系统的包封效率和信号蛋白的释放。图1:HES衍生物的化学结构图2:从HES衍生物制备块状水凝胶和可注射的微粒结果和讨论:水凝胶网络的筛孔大小可通过取代度和聚合物浓度进行调节。当由相同的聚合物和浓度制备时,本体水凝胶和微粒具有相似的结构和释放曲线。荧光各向异性的结果表明在水凝胶中GFP旋转不受限制,而FRAP测量表明GFP的翻译迁移率在水凝胶中受到限制。体外和体内释放速率的比较表明了良好的可比性,这取决于用于体外实验的受体介质。壳聚糖/ TPP纳米粒子非常适合传递生物活性BMP2。结论:水凝胶以微米或纳米颗粒的形式非常适合用于治疗性蛋白质的递送。通过调整制备方法,可以调整药物释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号